Spectra Systems Corporation

Transaction in Own Shares • Nov 26, 2025

National Storage Mechanism | Additional information

RNS Number : 9927I

Spectra Systems Corporation

26 November 2025

26 November 2025
Spectra Systems Corporation
("Spectra" or the "Company")
Transaction in Own Shares & TVR
Spectra Systems Corporation (AIM: SPSY), a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, announces that it purchased 10,000 unrestricted common shares of US$0.01 each in the Company (the "Repurchased Shares"). This share repurchase was carried out in accordance with Delaware General Corporation Law.
Date of purchase		25 November 2025
Number of ordinary shares purchased		10,000
Highest price paid per ordinary share		126.8 pence
Lowest price paid per ordinary share		126.8 pence
Volume weighted average price paid per ordinary share		126.8 pence
Total Voting Rights
Following the Transaction, the issued share capital of the Company remains unchanged at 48,300,689 and the Company now holds 10,000 shares in treasury. The total voting rights in the Company is now 48,290,689 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Spectra Systems under the FCA's Disclosure Guidance and Transparency Rules.
The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 details of the purchase of its own ordinary shares by the Company, which were all executed through the Company's broker, Zeus Capital Limited, are set out below:
Schedule of Purchases:
Shares purchased:	Spectra Systems Corporation  (ISIN: US84756T1060)
Date of purchases:	25 November 2025
Individual transactions:
Volume	Price	Date and Time
10,000	126.8000 pence	25/11/2025 13:42 UK
Spectra Systems Corporation
Dr. Nabil Lawandy, Chief Executive Officer			Tel: +1 (0)401 274 4700
Zeus (Nominated Advisor and Joint Broker)			Tel: +44 (0)20 3829 5000
James Joyce / James Bavister (Investment Banking )
Fraser Marshall (Corproate Broking)
Allenby Capital Limited (Joint Broker)
Nick Naylor/James Reeve (Corporate Finance)			Tel: +44 (0)20 3328 5665
Amrit Nahal (Sales and Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSDGBDBRUDDGUU